Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDCalliditas Thera Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
Calliditas Thera Earnings Date And Information
Calliditas Thera last posted its earnings results on Monday, November 11th, 2024. The company reported $-0.58 earnings per share for the quarter, missing analysts' consensus estimates of $-0.22 by $0.36. The company had revenue of 559.78 M for the quarter and had revenue of 1.21 B for the year. Calliditas Thera has generated $-17 earnings per share over the last year ($-17.38 diluted earnings per share) and currently has a price-to-earnings ratio of -23.95. Calliditas Thera has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Calliditas Thera Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/13/2024 | Q2 2024 | -$0.10 | -$1.76 | -1.66 | $454.87 M | $559.78 M |
| 04/25/2024 | Q1 2024 | N/A | -$9.18 | N/A | N/A | $295.48 M |
| 04/24/2024 | Q4 2023 | N/A | -$0.68 | N/A | N/A | $451.56 M |
| 09/29/2023 | Q3 2023 | N/A | -$6.28 | N/A | $325.21 M | $294.59 M |
| 08/17/2023 | Q2 2023 | -$0.17 | -$3.42 | -3.25 | $292.22 M | $269.38 M |
| 04/28/2023 | Q1 2023 | N/A | -$6.98 | N/A | $230.12 M | $191.35 M |
| 04/26/2023 | Q4 2022 | N/A | -$0.14 | N/A | $195.82 M | $429.04 M |
| 09/29/2022 | Q3 2022 | N/A | -$0.34 | N/A | $132.95 M | $260.06 M |
| 06/30/2022 | Q2 2022 | N/A | -$7.24 | N/A | $80.21 M | $64.05 M |
| 04/29/2022 | Q1 2022 | N/A | -$7.90 | N/A | $48.83 M | $49.73 M |
| 04/27/2022 | Q4 2021 | N/A | -$8.38 | N/A | N/A | $31.18 M |
| 09/29/2021 | Q3 2021 | N/A | $0.42 | N/A | N/A | $198.17 M |
| 06/29/2021 | Q2 2021 | N/A | -$6.40 | N/A | N/A | $0 |
| 03/30/2021 | Q1 2021 | N/A | -$5.02 | N/A | $116.39 K | $0 |
| 04/27/2021 | Q4 2020 | N/A | -$6.84 | N/A | N/A | $400.00 K |
| 09/29/2020 | Q3 2020 | N/A | -$5.55 | N/A | N/A | $0 |
| 06/29/2020 | Q2 2020 | N/A | -$3.00 | N/A | N/A | $0 |
| 03/30/2020 | Q1 2020 | N/A | -$3.30 | N/A | N/A | $474.00 K |
| 12/30/2019 | Q4 2019 | N/A | -$1.22 | N/A | N/A | $46.59 M |
| 09/29/2019 | Q3 2019 | N/A | -$2.60 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Calliditas Thera Earnings: FAQ's
The conference call for Calliditas Thera's latest earnings report can be listened to online.
The conference call transcript for Calliditas Thera's latest earnings report can be read online.
Calliditas Thera (:CALT) has a recorded annual revenue of $1.21 B.
Calliditas Thera (:CALT) has a recorded net income of $-466,185,000.Calliditas Thera has generated $-17.38 earnings per share over the last four quarters.
Calliditas Thera (:CALT) has a price-to-earnings ratio of -23.95 and price/earnings-to-growth ratio is 0.41.